Cascade-Responsive Nanoparticles for Efficient CRISPR/Cas9-Based Glioblastoma Gene Therapy
ACS Applied Materials & Interfaces · 22.01.2025 · 17 (3) · 4480-4489
DOI: 10.1021/acsami.4c15671 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 11.01.2025. Verfasst von Qiushi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Functional Polymer Materials of Ministry of Education, College of Chemistry, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: Glioblastoma, CRISPR-Cas Systems, Nanoparticles, Genetic Therapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Nankai University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Functional Polymer Materials of Ministry of Education, College of Chemistry, Nankai University, Tianjin 300071, China.
- State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.
- School of Medical Imaging, Tianjin Medical University, Tianjin 300203, China.
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
ORCID-Profile: Yang Liu
Förderung
- Nankai University
- National Natural Science Foundation of China
Zitieren
APA
Li, Q., Zhang, Z., Wu, X., Zhao, Y., & Liu, Y. (2025). Cascade-Responsive Nanoparticles for Efficient CRISPR/Cas9-Based Glioblastoma Gene Therapy. ACS Applied Materials & Interfaces, 17(3), 4480-4489. https://doi.org/10.1021/acsami.4c15671
Vancouver
Li Q, Zhang Z, Wu X, Zhao Y, Liu Y. Cascade-Responsive Nanoparticles for Efficient CRISPR/Cas9-Based Glioblastoma Gene Therapy. ACS Applied Materials & Interfaces. 2025;17(3):4480-4489. doi:10.1021/acsami.4c15671
BibTeX
@article{Li2025,
author = {Li, Qiushi and Zhang, Zhanzhan and Wu, Xueyao and Zhao, Yu and Liu, Yang},
title = {Cascade-Responsive Nanoparticles for Efficient CRISPR/Cas9-Based Glioblastoma Gene Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {3},
pages = {4480--4489},
doi = {10.1021/acsami.4c15671}
}
EUVIMED